1
|
Bednarski B, Williams MC, Pieszko K, Miller RJH, Huang C, Kwiecinski J, Sharir T, Di Carli M, Fish MB, Ruddy TD, Hasuer T, Miller EJ, Acampa W, Berman DS, Slomka PJ. Unsupervised machine learning improves risk stratification of patients with visual normal SPECT myocardial perfusion imaging assessments. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.300] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Unsupervised machine learning has the potential to identify new cardiovascular phenotypes and more accurately assess individual risk in an unbiased fashion.
Purpose
We aimed to use unsupervised learning to identify, analyze, and risk-stratify subgroups of patients with normal perfusion by visual interpretation on single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI).
Methods
We included consecutive patients with visual normal clinical assessment (summed stress score of 0) from the multicenter (9 sites), REFINE SPECT registry. We considered 23 clinical, 17 image-acquisition, and 26 imaging variables. Optimal dimensionality reduction (Uniform Manifold Approximation and Projection), clustering (Gaussian Mixture Model), and number of clusters were selected to maximize the silhouette coefficient (how similar a patient is to those in their own cluster compared to other clusters). Risk stratification for all-cause mortality (ACM) and major adverse cardiac events (MACE) was assessed within these clusters and compared to risk stratification by quantitative ischemia (<5%, 5–10%, >10%) using Kaplan-Meier curves and Cox Proportional-Hazards analysis.
Results
In total, 17,527 (of 30,351) patients in the registry had visually normal perfusion, 49.7% female, median age of 64 [55, 72] years. There were 1,138 ACM events and 2,091 MACE events with a median follow-up of 4.1 [2.9, 5.7] years. Unsupervised learning provided better risk stratification for both ACM and MACE compared to quantitative ischemia (Figure). Notably, the high-risk cluster by unsupervised learning had a hazard ratio (HR) of 9.5 (95% confidence interval [CI]: 7.7–11.7) compared to 1.4 (95% CI: 1.1–1.9) for quantitative ischemia >10%. The high-risk cluster had proportionally more women (45% [low-risk], 51% [medium-risk], 57% [high-risk], all p<0.001), higher body mass indices (26.9, 27.4, 29.6, all p<0.001), prevalence of diabetes (17%, 22%, 33%, all p<0.001), and abnormal rest ECGs (30%, 43%, 64%, p<0.001); with lower rates of family history of coronary artery disease (40%, 33%, 24%, p<0.001). Patients in the low-risk cluster were more likely to undergo exercise stress (100%, 38%, 0%, all p<0.001), had lower rest peak systolic blood pressure (130, 131, 140 mmHg, all p<0.001), and higher stress peak systolic blood pressure (164, 150, 131 mmHg, all p<0.001). Patients in the high-risk cluster had higher left ventricular mass (129, 135.45, 143.9 g, all p<0.001) and stress volume (57, 59, 66 ml, all p<0.001).
Conclusion
Unsupervised learning identified new phenotypic clusters for SPECT MPI patients with visual normal assessments which provided improved risk stratification for ACM and MACE compared to SPECT ischemia. Such individualized risk assessment may allow better targeted management of patients with visually normal perfusion.
Funding Acknowledgement
Type of funding sources: Public Institution(s). Main funding source(s): Research reported in this publication was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number R01HL089765. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Collapse
Affiliation(s)
- B Bednarski
- Cedars-Sinai Medical Center , Los Angeles , United States of America
| | - M C Williams
- University of Edinburgh , Edinburgh , United Kingdom
| | - K Pieszko
- Cedars-Sinai Medical Center , Los Angeles , United States of America
| | - R J H Miller
- University of Calgary, Libin Cardiovascular Institue , Calgary , Canada
| | - C Huang
- Cedars-Sinai Medical Center , Los Angeles , United States of America
| | | | - T Sharir
- Assuta Medical Center , Tel Aviv , Israel
| | - M Di Carli
- Brigham and Women's Hospital, Department of Radiology , Boston , United States of America
| | - M B Fish
- Sacred Heart Medical Center, Department of Nuclear Medicine, Oregon Heart and Vascular Institute, Springfield , Oregon , United States of America
| | - T D Ruddy
- University of Ottawa Heart Institute , Ottawa , Canada
| | - T Hasuer
- Oklahoma Heart Hospital , Oklahoma City , United States of America
| | - E J Miller
- Yale University School of Medicine, Section of Cardiovascular Medicine, New Haven , CT , United States of America
| | - W Acampa
- University of Naples Federico II, Department of Advanced Biomedical Sciences , Naples , Italy
| | - D S Berman
- Cedars-Sinai Medical Center , Los Angeles , United States of America
| | - P J Slomka
- Cedars-Sinai Medical Center , Los Angeles , United States of America
| |
Collapse
|